Search results
Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
Yahoo Finance· 1 year agoModerna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP...
Moderna's billionaire CEO reaped nearly $400 million last year. He also got a raise.
Washington Post via Yahoo News· 1 year agoStéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that...
Democrats blast Moderna CEO over plans to quadruple price of COVID-19 vaccine
The Hill via Yahoo News· 1 year agoDemocratic senators lashed out at Moderna CEO Stéphane Bancel in a Thursday hearing over his...
Moderna: Stock soars on cancer vaccine data, CEO Bancel takes on commercial role
Yahoo Finance· 5 months agoShares of Moderna soared around 14% on Thursday on the news that a personalized cancer vaccine,...
Moderna CEO grilled over plan to raise Covid vaccine price
NBC News via Yahoo News· 1 year agoModerna CEO Stéphane Bancel defended plans to raise the price of the company's Covid vaccine, saying...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 2 weeks agoKey Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna CEO: COVID variant vaccine to be ready for shipping in August
Reuters via Yahoo Sports· 2 years agoModerna's COVID-19 variant vaccine will be ready to ship in August as the company has been making...
Moderna's CEO To Appear Before Senate On Quadrupling COVID-19 Vaccine Prices
Benzinga via Yahoo Finance· 1 year agoModerna Inc's (NASDAQ: MRNA) CEO, Stéphane Bancel, will testify next month on its plans to raise the...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 5 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...